The changing epidemiology of viral hepatitis B in Iran

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 4, 2007, Pages 403-406

  Alavian, Seyed Moayed ^a,c   Fallahian, Farahnaz ^a   Lankarani, Kamran Bagheri ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

Author keywords

Epidemiology; Hepatitis B; Hepatitis transmission; Iran; Middle East

Indexed keywords

CLINICAL PRACTICE; DISINFECTION; ENDEMIC DISEASE; HEALTH CARE; HEALTH PROGRAM; HEPATITIS B; HUMAN; INSTRUMENT STERILIZATION; IRAN; MARRIAGE; PREVALENCE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; VACCINATION; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, HORIZONTAL; HEPATITIS B; HUMANS; IRAN; MORBIDITY; RISK FACTORS;

EID: 37549002137     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
2. Lai CL. Chronic hepatitis B in Hong Kong: immunization strategies for the control of hepatitis B virus infection. In: Zuckerman, ed. Hepatitis B in the Asian-Pacific region vol. 1 screening, diagnosis and control. London: Royal College of Physician, 1997: 79-87.
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11: 97-107.
4. Kowdley KV. The cost of managing chronic hepatitis B infection: a global perspective. J Clin Gastroenterol. 2004; 38: S132-S133.
5. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18: S20-22.
6. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang 1979; 37: 182-186.
7. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000; 3: 192-201.
8. Bagheri Lankarani K, Saberi Froozi M, Nabipoor I, et al. Reassesment of the role of hepatitis B and C viruses in southern Iran. Iran J Med Sci 1999; 24: 117-121.
9. Shamszad M, Farzadegan H. Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran. J Iran Med Council 1982; 8: 228.
10. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J 2005; 11: 62-67.
11. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J 2003; 24: 549-551.
12. Bozergi SH, Ahmadzad Asl M, Ramazani H, Kargarfard H, Alavian SM. Study of viral infections prevalence in blood donors of Qazvin province in different time intervals and during Bam earthquake. Govaresh 2007; 11: 242-248.
13. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol 2006; 12: 5211-5213.
14. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76: 318-326.
15. Sali S, Bashtar R, Alavian SM. Risk factors in chronic hepatitis B infection: A case-control study. Hep Mon 2005; 5: 109-115.
16. Alavian SM, Mostajabi P, Malekzadeh R, , et al. Evaluation of hepatitis B transmission risk factors in Tehran blood donors. Govaresh 2004; 9: 169-175.
17. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003; 21: 1948-1951.
18. Hosseini Asl SK, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in Gypsy population residing in Shahr-E-Kord. Arch Iran Med 2004; 7: 20-22.
19. Alizadeh AH, Ranjbar M, Ansari S, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J 2006; 12: 528-537.
20. Alizadeh AH, Ranjbar M, Ansari S, et al. Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol. 2005; 11: 4857-4860.
21. Ghanaat J, Sadeghian A, Ghazvini K, Nassiri MR. Prevalence and risk factors for hepatitis B virus infections among STD patients in northeast region of Iran. Med Sci Monit 2003; 9: CR91-94.
22. Askarian M, Khalooee A, Emroodi NN. Personal hygiene and safety of governmental hospital staff in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2006; 12: 768-774.
23. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006; 21: 299-305.
24. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 2004; 26: 225-228.
25. Ameen R, Sanad N, Al-Shemmari S, et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005; 45: 1973-1980.
26. Quddus A, Luby SP, Jamal Z, Jafar T. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan. Int J Infect Dis 2006; 10: 242-247.
27. Fung SK, Wong FS, Wong DK, Hussain MT, Lok AS. Hepatitis B virus genotypes, precore and core promoter variants among predominantly Asian patients with chronic HBV infection in a Canadian center. Liver Int 2006; 26: 796-804.
28. Al-Shamahy H. Prevalence of hepatitis B surface antigen and risk factors of HBV infection in a sample of healthy mothers and their infants in Sana'a, Yemen. Ann Saudi Med 2000; 20: 5-6.
29. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-774.
30. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, et al. Seroepidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect 2006; 52:202-206.
31. Saab BR, Nassar NT, Musharrafieh U, Araj GF, Khogali M. Prevalence of hepatitis B in a presumably healthy Lebanese population. J Med Liban 2007; 55: 11-14.
32. Toukan AU. Strategy for the control of hepatitis B virus infection in the middle East and North Africa. Middle East Regional Study Group. Vaccine 1990; 8: S117-S121.
33. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBs detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237-241.
34. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117: 313-325.
35. Ali HY. Hepatitis B infection among Iraqi children: the impact of sanctions. East Mediterr Health J 2004; 10: 6-11.
36. Janjua NZ, Hutin YJ, Akhtar S, Ahmad K. Population beliefs about the efficacy of injections in Pakistan's Sindh province. Public Health 2006; 120: 824-833.
37. Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem-Ur-Rehman, Wray N. High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan. Harm Reduct J 2007; 4: 7.